Results 21 to 30 of about 53,816 (275)

Stereotactic body radiation therapy for inoperable localized kidney cancer

Сибирский онкологический журнал, 2023
Purpose of the study: to evaluate the overall survival and local control in patients with inoperable kidney cancer treated with stereotactic body radiotherapy (SBRT).Material and Methods. From 2011 to 2021, 42 patients with histologically verified kidney
Zh. E. Sabelnikova, M. M. Sarycheva, E. Ya. Mozerova, A. V. Vazhenin   +3 more
doaj   +1 more source

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy. [PDF]

, 2018
Purpose/objectivesFor lung stereotactic body radiation therapy (SBRT), real-time tumor tracking (RTT) allows for less radiation to normal lung compared to the internal target volume (ITV) method of respiratory motion management. To quantify the advantage
Bahig, Baker, Barriger, Benedict, Bibault, Borst, Braunstein, Brown, Chang, Depuydt, Descovich, Fowler, Gibbs, Gopal, Guckenberger, Harder, Hoogeman, Jung, Keall, Kim, Movsas, Onishi, Ricardi, Seppenwoolde, Shah, Thariat, Trumm, Tsoutsou, Videtic, Wang, Wennberg, Withers, Yamashita   +32 more
core   +2 more sources

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)

Clinical and Translational Radiation Oncology, 2020
Background: There is increasing interest in treating oligometastatic non-small cell lung cancer (NSCLC) patients with stereotactic radiation. We aimed to address whether patients definitively treated with synchronous thoracic stereotactic body radiation ...
John Nikitas, Michael Roach, Cliff Robinson, Jeffrey Bradley, Jiayi Huang, Stephanie Perkins, Christina Tsien, Christopher Abraham   +7 more
doaj   +1 more source

How to integrate stereotactic body radiation therapy and hypofractionation in the management of stage III lung cancer in the age of immunotherapy

Anales del Sistema Sanitario de Navarra, 2020
The constant advances in the field of lung cancer immunotherapy have recently reached the treatment of locally advanced disease with the approval of durvalumab after concurrent chemoradiation.
M. Rico, S. Flamarique Andueza, A. Martín Martínez, M.A. Rodríguez Mendizábal, L. Rosas Gutiérrez, E. Martínez López   +5 more
doaj   +1 more source

Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report. [PDF]

, 2018
We present a case of durable local control achieved in a patient treated with stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) for an abdominal lymph node in the setting of oligometastatic breast cancer.
Cao, Minsong, Dang, Audrey, Lamb, James, Lee, Percy, Low, Daniel A, Raldow, Ann C, Steinberg, Michael L, Tyran, Marguerite   +7 more
core   +1 more source

A dose falloff gradient study in RapidArc planning of lung stereotactic body radiation therapy

Journal of Medical Physics, 2018
Introduction: Radiation Therapy Oncology Group (RTOG) report #0813 and 0915 recommends using D2cmand R50%as plan quality metrics for evaluation of normal tissue sparing in stereotactic body radiation therapy (SBRT) of lung lesion.
Ganesh Narayanasamy, Dharmin Desai, Sanjay Maraboyina, Jose Penagaricano, Robert Zwicker, Ellis Lee Johnson   +5 more
doaj   +1 more source

Rethinking the Role of Radiation Therapy in the Management of Epithelial Ovarian Cancer

Diagnostics, 2020
Radiation has been relegated to a palliative role in the management of epithelial ovarian cancer (EOC). Contemporary radiation techniques, including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and image ...
Geraldine Jacobson, Valerie Galvan-Turner   +1 more
doaj   +1 more source

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation

Advances in Radiation Oncology, 2022
Purpose: Whole gland cryoablation is a guideline-approved definitive treatment for localized prostate cancer, and is being explored for partial gland ablation. However, there is limited data regarding management of cryoablation failures.
Jonathan W. Lischalk, MD, Aaron E. Katz, MD, Seth R. Blacksburg, MD, MBA, Christopher Mendez, MA, Astrid Sanchez, MS, Michael C. Repka, MD, Matthew Witten, PhD, Samir Taneja, MD, Herbert Lepor, MD, Jonathan A. Haas, MD   +9 more
doaj   +1 more source

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

Frontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani, Giovanni eAguzzi, David eSchaal, Pantaleo eRomanelli   +3 more
doaj   +1 more source

Changing paradigm of radiation therapy for the treatment of pancreatic cancer

Precision Radiation Oncology, 2019
The evidence supporting the use of radiation therapy (RT) for pancreatic cancer (PC) treatment is highly variable, with studies both showing and failing to show that RT provides a survival benefit.
Beth K Neilsen, Chi Lin
doaj   +1 more source